US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nascent Biotech Inc.

0.0003

0.0000

Volume:- -

Turnover:- -

Market Cap:51.85K

PE:-0.03

High:0.0003

Open:0.0003

Low:0.0003

Close:0.0003

52wk High:0.1345

52wk Low:0.0000

Shares:172.84M

Float Shares:86.08M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0118

EPS(LYR):-0.0134

ROE:57.27%

ROA:-854.34%

PB:-0.10

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Nascent Biotech Inc.

Exchange:

EXPERT

Establishment Date:

- -

Employees:

- -

Office Location:

631 US Hwy 1,Suite 407,North Palm Beach,Florida,United States

Website:

http://www.nascentbiotech.com

Zip Code:

33408

Phone:

Fax:

- -

Introduction:

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. The company has collaboration with Hypospray Pharma to develop an alternative delivery mechanism for patients who can benefit from Pritumumab. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NBIO/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIO\",,,,,undefined,":{"symbol":"NBIO","market":"US","secType":"STK","nameCN":"Nascent Biotech Inc.","latestPrice":0.0003,"timestamp":1772053200000,"preClose":0.0003,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":86083799,"shares":172842665,"eps":-0.011778,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-25 16:00:00 EST Delay","open":0.0003,"high":0.0003,"low":0.0003,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.011778,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772096400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0003,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIO\",,,,,undefined,":{"symbol":"NBIO","floatShares":86083799,"roa":"-854.34%","roe":"57.27%","lyrEps":-0.013404,"shares":172842665,"dividePrice":0,"high":0.0003,"amplitude":0,"preClose":0.0003,"low":0.0003,"week52Low":0.000001,"pbRate":"-0.10","week52High":0.1345,"institutionHeld":0,"latestPrice":0.0003,"eps":-0.011778,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.011778,"open":0.0003,"prevYearClose":0.0006,"prevWeekClose":0.0003,"prevMonthClose":0.0003,"prevQuarterClose":0.0006,"fiveDayClose":0.0003,"twentyDayClose":0.0005,"sixtyDayClose":0.0043},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-14","symbol":"NBIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-07-01","symbol":"NBIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1719806400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-14","symbol":"NBIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707886800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-08-18","symbol":"NBIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1692331200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBIO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":269280380,"address":"631 US Hwy 1,Suite 407,North Palm Beach,Florida,United States","zipCode":"33408","officePhone":"612 961 5656"},"stockCompanyDetail":{"websiteUrl":"http://www.nascentbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0707},{"period":"1month","weight":-0.3444},{"period":"3month","weight":-0.3429},{"period":"6month","weight":-0.2691},{"period":"1year","weight":-0.3495},{"period":"ytd","weight":-0.2347}],"description":"Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. The company has collaboration with Hypospray Pharma to develop an alternative delivery mechanism for patients who can benefit from Pritumumab. Nascent Biotech, Inc. is based in North Palm Beach, Florida.","exchange":"EXPERT","name":"Nascent Biotech Inc.","nameEN":"Nascent Biotech Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NBIO\",market:\"US\",,,undefined,":null}}